# Efficacy of Adaptogens in Patients With Long COVID-19

> **NCT04795557** · PHASE2,PHASE3 · COMPLETED · sponsor: **Swedish Herbal Institute AB** · enrollment: 100 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** ADAPT-232 oral solution
- **OTHER:** Placebo oral solution

## Key facts

- **NCT ID:** NCT04795557
- **Lead sponsor:** Swedish Herbal Institute AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2021-11-11
- **Final completion:** 2021-12-26
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-12-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795557, "Efficacy of Adaptogens in Patients With Long COVID-19". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04795557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*